Table 1. Patient Characteristics and... | American Society of Hematology

Table 1.

Patient Characteristics and Treatment at Initial Presentation

Patient	Age (yr; diagnosis/ relapse)	Sex	WCC (10⁹/L)	Immunophenotype	Karyotype	Treatment	CR1 Duration (yr)	Clonal Marker
1	10/34	M	14	NK	NK	UKALL I	24	IgH FR2 (260 bp)
2	11/21	F	2	NK	NK	UKALL III	10	Failed^*
3	3/13	F	18	NK	NK	UKALL V	10	IgH FR3 (125 bp)
4	11/31	M	12	CD10⁺	NK	UKALL V	20	IgH FR3 (120 bp)
5	4/15	F	10	NK	NK	UKALL V	11	Failed^*
6	3/13	M	14	CD10⁺	Normal	UKALL V	14	IgH FR3 (130 bp)
7	8/22	F	2	NK	NK	UKALL V	14	IgH FR2 (250 bp)
8	7/19	F	8	CD10⁺	NK	UKALL V	11	IgH FR3
9	7/18	M	60	NK	NK	UKALL VI	11	TCRδ (vδ2-Dδ-Dδ3 240 bp)
10	5/18	F	21	CD10⁺	NK	UKALL VIII	12	IgH FR3 (120 bp)
11	7/19	M	8	CD10⁺	NK	UKALL VIII	12	Failed^*
12	4/14	M	2	CD10⁺	46 XY Gq ?Ph	UKALL VIII	10	Failed^*
Median (range)	7 (3-11)		11 (2-60)				12 (10-24)

Patient	Age (yr; diagnosis/ relapse)	Sex	WCC (10⁹/L)	Immunophenotype	Karyotype	Treatment	CR1 Duration (yr)	Clonal Marker
1	10/34	M	14	NK	NK	UKALL I	24	IgH FR2 (260 bp)
2	11/21	F	2	NK	NK	UKALL III	10	Failed^*
3	3/13	F	18	NK	NK	UKALL V	10	IgH FR3 (125 bp)
4	11/31	M	12	CD10⁺	NK	UKALL V	20	IgH FR3 (120 bp)
5	4/15	F	10	NK	NK	UKALL V	11	Failed^*
6	3/13	M	14	CD10⁺	Normal	UKALL V	14	IgH FR3 (130 bp)
7	8/22	F	2	NK	NK	UKALL V	14	IgH FR2 (250 bp)
8	7/19	F	8	CD10⁺	NK	UKALL V	11	IgH FR3
9	7/18	M	60	NK	NK	UKALL VI	11	TCRδ (vδ2-Dδ-Dδ3 240 bp)
10	5/18	F	21	CD10⁺	NK	UKALL VIII	12	IgH FR3 (120 bp)
11	7/19	M	8	CD10⁺	NK	UKALL VIII	12	Failed^*
12	4/14	M	2	CD10⁺	46 XY Gq ?Ph	UKALL VIII	10	Failed^*
Median (range)	7 (3-11)		11 (2-60)				12 (10-24)

*Failed DNA extraction.